IL-13 signaling via IL-13Rα2 triggers TGF-β1-dependent allograft fibrosis

Transplantation Research

Volumn 2, Issue 1, 2013, Pages

  Brunner, Stefan M ^a   Schiechl, Gabriela ^a   Kesselring, Rebecca ^a   Martin, Maria ^a   Balam, Saidou ^a   Schlitt, Hans J ^a   Geissler, Edward K ^a   Fichtner Feigl, Stefan ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Allograft fibrosis; Heart transplantation; IL 13; IL 13R 2; TGF 1

Indexed keywords

BETA 2 MICROGLOBULIN; CD11 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COLLAGEN; COLLAGENASE 3; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERSTITIAL COLLAGENASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MOUSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; SIGNAL TRANSDUCTION; SPLEEN CELL; UPREGULATION; WESTERN BLOTTING;

EID: 84899121448     PISSN: None     EISSN: 20471440     Source Type: Journal    
DOI: 10.1186/2047-1440-2-16     Document Type: Article

References (38)

1. Booth AJ, Csencsits-Smith K, Wood SC, Lu G, Lipson KE, Bishop DK. Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection. Am J Transplant 2010, 10:220-230. 10.1111/j.1600-6143.2009.02826.x, 2860022, 19788504.
2. Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. Transplantation 2013, 95:629-634. 10.1097/TP.0b013e318277e378, 23423270.
3. Savasta M, Lentini S. Immunology insights into cardiac allograft rejection. Rev Cardiovasc Disord 2011, 12:e68-e76.
4. Huibers M, De Jonge N, Van Kuik J, Koning ES, Van Wichen D, Dullens H, Schipper M, De Weger R. Intimal fibrosis in human cardiac allograft vasculopathy. Transpl Immunol 2011, 25:124-132. 10.1016/j.trim.2011.07.001, 21782945.
5. Pichler M, Rainer PP, Schauer S, Hoefler G. Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. J Am Coll Cardiol 2012, 59:1008-1016. 10.1016/j.jacc.2011.11.036, 22402073.
6. Suzuki J, Isobe M, Morishita R, Nagai R. Characteristics of chronic rejection in heart transplantation: important elements of pathogenesis and future treatments. Circ J 2010, 74:233-239. 10.1253/circj.CJ-09-0809, 20009354.
7. Booth AJ, Bishop DK. TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection. Immunotherapy 2010, 2:511-520. 10.2217/imt.10.33, 2931419, 20636005.
8. Faust SM, Lu G, Marini BL, Zou W, Gordon D, Iwakura Y, Laouar Y, Bishop DK. Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection. J Immunol 2009, 183:7297-7306. 10.4049/jimmunol.0902446, 2819141, 19917689.
9. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 2006, 12:99-106. 10.1038/nm1332, 16327802.
10. Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schlitt HJ, Strober W. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 2008, 135:2003-2013. 2013 e1-7, 10.1053/j.gastro.2008.08.055, 18938165.
11. Calabrese F, Kipar A, Lunardi F, Balestro E, Perissinotto E, Rossi E, Nannini N, Marulli G, Stewart JP, Rea F. Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis. PLoS One 2013, 8:e55715. 10.1371/journal.pone.0055715, 3585298, 23468849.
12. Faust SM, Lu G, Wood SC, Bishop DK. TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection. J Immunol 2009, 183:7307-7313. 10.4049/jimmunol.0902736, 3046403, 19917705.
13. Harris S, Coupes BM, Roberts SA, Roberts IS, Short CD, Brenchley PE. TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol 2007, 20:177-185.
14. Tanaka M, Zwierzchoniewska M, Mokhtari GK, Terry RD, Balsam LB, Robbins RC, Fedoseyeva EV. Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Am J Transplant 2005, 5:1286-1296. 10.1111/j.1600-6143.2005.00880.x, 15888032.
15. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973, 16:343-350. 10.1097/00007890-197310000-00010, 4583148.
16. Shimamura M, Morishita R, Endoh M, Oshima K, Aoki M, Waguri S, Uchiyama Y, Kaneda Y. HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophysic Res Comm 2003, 300:464-471.
17. Fichtner-Feigl S, Fuss IJ, Young CA, Watanabe T, Geissler EK, Schlitt HJ, Kitani A, Strober W. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol 2007, 178:5859-5870.
18. Aliprantis AO, Wang J, Fathman JW, Lemaire R, Dorfman DM, Lafyatis R, Glimcher LH. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci USA 2007, 104:2827-2830. 10.1073/pnas.0700021104, 1815266, 17307869.
19. Jakubzick C, Choi ES, Joshi BH, Keane MP, Kunkel SL, Puri RK, Hogaboam CM. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol 2003, 171:2684-2693.
20. Keane MP, Gomperts BN, Weigt S, Xue YY, Burdick MD, Nakamura H, Zisman DA, Ardehali A, Saggar R, Lynch JP, Hogaboam C, Kunkel SL, Lukacs NW, Ross DJ, Grusby MJ, Strieter RM, Belperio JA. IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome. J Immunol 2007, 178:511-519.
21. Strober W, Kitani A, Fichtner-Feigl S, Fuss IJ. The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance. Curr Mol Med 2009, 9:740-750. 10.2174/156652409788970652, 19689301.
22. Rahmutula D, Marcus GM, Wilson EE, Ding CH, Xiao Y, Paquet AC, Barbeau R, Barczak AJ, Erle DJ, Olgin JE. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-beta1. Cardiovasc Res 2013, 99:769-779. 10.1093/cvr/cvt074, 23612580.
23. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian Lynn M, Richmond A, Lin PC, Moses HL. Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008, 13:23-35. 10.1016/j.ccr.2007.12.004, 2245859, 18167337.
24. Fichtner-Feigl S, Terabe M, Kitani A, Young CA, Fuss I, Geissler EK, Schlitt HJ, Berzofsky JA, Strober W. Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2. Cancer Res 2008, 68:3467-3475. 10.1158/0008-5472.CAN-07-5301, 2746996, 18451175.
25. Terabe M, Matsui S, Park J-M, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA. Transforming growth factor-β production and myeloid cells Are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med 2003, 198:1741-1752. 10.1084/jem.20022227, 2194133, 14657224.
26. Fu S, Zhang N, Yopp AC, Chen D, Mao M, Zhang H, Ding Y, Bromberg JS. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors. Am J Transplant 2004, 4:1614-1627. 10.1111/j.1600-6143.2004.00566.x, 15367216.
27. Lan Q, Zhou X, Fan H, Chen M, Wang J, Ryffel B, Brand D, Ramalingam R, Kiela PR, Horwitz DA, Liu Z, Zheng SG. Polyclonal CD4 + Foxp3+ Treg cells induce TGFbeta-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome. J Mol Cell Biol 2012, 4:409-419. 10.1093/jmcb/mjs040, 3523557, 22773728.
28. Tran DQ. TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol 2012, 4:29-37. 10.1093/jmcb/mjr033, 22158907.
29. Zheng SG, Wang J, Horwitz DA. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 2008, 180:7112-7116.
30. Bandinelli F, Del Rosso A, Gabrielli A, Giacomelli R, Bartoli F, Guiducci S, Matucci Cerinic M. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment. Clin Exp Rheumatol 2012, 30:S44-S49.
31. Kamari Y, Shaish A, Vax E, Shemesh S, Kandel-Kfir M, Arbel Y, Olteanu S, Barshack I, Dotan S, Voronov E, Dinarello CA, Apte RN, Harats D. Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol 2011, 55:1086-1094. 10.1016/j.jhep.2011.01.048, 3210940, 21354232.
32. Makino H, Aono Y, Azuma M, Kishi M, Yokota Y, Kinoshita K, Takezaki A, Kishi J, Kawano H, Ogawa H, Uehara H, Izumi K, Sone S, Nishioka Y. Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice. J Med Invest 2013, 60:127-137.
33. Nagai T, Tanaka M, Hasui K, Shirahama H, Kitajima S, Yonezawa S, Xu B, Matsuyama T. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis. Clin Exp Immunol 2010, 161:348-356. 2909418, 20550546.
34. Lopez AD, Avasarala S, Grewal S, Murali AK, London L. Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome. J Immunol 2009, 183:8244-8257. 10.4049/jimmunol.0901958, 2814248, 20007588.
35. Sato M, Hwang DM, Guan Z, Yeung JC, Anraku M, Wagnetz D, Hirayama S, Waddell TK, Liu M, Keshavjee S. Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation. Am J Pathol 2011, 179:1287-1300. 10.1016/j.ajpath.2011.05.032, 3157248, 21763265.
36. Zhao T, Zhao W, Chen Y, Li V, Meng W, Sun Y. Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2013, 304:H1719-H1726. 10.1152/ajpheart.00130.2013, 23585135.
37. Farkas L, Farkas D, Gauldie J, Warburton D, Shi W, Kolb M. Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am J Respir Cell Moll Biol 2011, 44:870-878.
38. Wang S, Sun A, Li L, Zhao G, Jia J, Wang K, Ge J, Zou Y. Up-regulation of BMP-2 antagonizes TGF-beta1/ROCK-enhanced cardiac fibrotic signalling through activation of Smurf1/Smad6 complex. J Cell Mol Med 2012, 16:2301-2310. 10.1111/j.1582-4934.2012.01538.x, 22283839.